Here’s Why Carillon Eagle Small Cap Sold Teladoc (TDOC)

Carillon Tower Advisers, an investment management firm, published its fourth quarter 2020 “Carillon Eagle Small Cap Growth Fund” investor letter – a copy of which can be downloaded here. In the letter, the fund talked about their best and worst securities, together with their outlook for this year from an investment perspective. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.

Carillon Eagle Small Cap Growth Fund, in their Q4 2020 investor letter, mentioned Teladoc Health, Inc. (NYSE: TDOC) and emphasized their views on the company. Teladoc Health, Inc. is a New York-based healthcare company that currently has a $26.1 billion market capitalization. Since the beginning of the year, TDOC delivered a -14.47% return, while its 12-month gains are still up by 7.23%. As of March 24, 2021, the stock closed at $181.99 per share.

Here is what Carillon Eagle Small Cap Growth Fund has to say about Teladoc Health, Inc. in their Q4 2020 investor letter:

“Teladoc Health offers remote physician access to patients at home. After experiencing incredible levels of growth throughout the early stages of the pandemic as its unique value proposition rose to the forefront of the healthcare industry, the firm’s shares cooled off a bit as optimistic vaccine data slightly curtailed investor expectations for the firm’s future growth potential. We sold the stock.”

one photo/

Our calculations show that Teladoc Health, Inc. (NYSE: TDOC) does not belong in our list of the 30 Most Popular Stocks Among Hedge Funds. As of the end of the fourth quarter of 2020, Teladoc Health, Inc. was in 50 hedge fund portfolios, compared to 47 funds in the third quarter. TDOC delivered a -17.41% return in the past 3 months.